| | Class 2 Device Recall AlphaOmega Services, Inc. TII0002 |  |
| Date Initiated by Firm | February 21, 2006 |
| Date Posted | April 27, 2006 |
| Recall Status1 |
Terminated 3 on August 30, 2006 |
| Recall Number | Z-0813-06 |
| Recall Event ID |
34969 |
| Product Classification |
System, Applicator, Radionuclide, Remote-Controlled - Product Code JAQ
|
| Product | TII0002 Implant Tube, Implant Tube, Intralumenal(HDR), 10CM Drawdown 130CM Body, Sealed End, Cable Insert & Gold Seed, Disposable |
| Code Information |
All Lots |
| FEI Number |
2022694
|
Recalling Firm/ Manufacturer |
Alpha Omega Services Inc 9156 Rose St Bellflower CA 90706
|
| For Additional Information Contact | Bob A. Robnett 562-804-0604 |
Manufacturer Reason for Recall | There is a possibility that the diameter of the catheter does not meet specifications. As a result it may not be possible to correctly connect the catheter to a VariSource Quick Connect. This would prevent any treatment. Furthermore, since the problem would not be apparent until after the catheter has been implanted an unnecessary surgical implantation procedure would have taken place. |
FDA Determined Cause 2 | Other |
| Action | Recall Notification Letter:
began February 22, 2006.
Depth/Scope:
100% of the customer''s who purchased the affected products will be identified and contacted with a faxed and mailed Medical Device Recall notice and followed up with a phone call by the AOS Sales & Marketing personnel. All customers will be requested return all affected products, both used and unused. |
| Quantity in Commerce | 260 |
| Distribution | Nationwide and Argentina, Brasil, Canada, Israel, Korea, , Taiwan, United Kingdom & Venezuela |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|